The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Endosoft sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Endosoft LLC (Endosoft) is a healthcare technology company that develops clinical and business workflow management applications. The company provides integrated application modules for nursing, pathology, anaesthesiology, scheduling, practice management, inventory management, sterilization, and database tools for reporting; and applications for gastroenterology, pulmonology, pain management, urology, general surgery, cardiology, orthopaedics, pathology, obstetrics and gynaecology, plastic surgery, podiatry, ophthalmology, and dermatology. It provides EndoVault EHR application that enables users to capture, store, and access a patient’s demographics, medical history, medications, vitals, laboratory tests, procedure images, and reports; and EndoVault Rx, an electronic prescription application for physicians. Endosoft’s oncology software provide cancer staging, cancer registry and reporting, providing pre-degree patient history, database query and auditing, consult progress and procedure note, chemo therapy, document management and other solutions. The company has operations in India, the Netherlands, the UK, Australia and the US. Endosoft is headquartered in Schenectady, New York, the US. Key subsidiaries of Endosoft include EndoSoft, EndoSoft, Endosoft Solutions and Endosoft.
The key metrics of Endosoft related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Endosoft is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Endosoft.
For a detailed understanding of the performance of Endosoft, buy the report here.